Recent Comments
- LB on The final House report on COVID
- Joy Smith on The Declaration of Pandemics
- Linnea Comstock on The Declaration of Pandemics
- Lance W Richardson on The Declaration of Pandemics
- Sarah on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (23,677)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (17,656)
- New treatment paradigm for C. Diff colitis (16,057)
- The Healthcare Channel hits 10 (15,520)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (15,308)
- How the FDA regulates compounding pharmacies (15,136)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,984)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (10,969)
- The new CDC guidelines for prescribing opioid pain pills (10,435)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (10,297)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Nutrition
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: – NEJM
Mechanical heart valves provide much lower mortality than tissue valves in young patients
November 8, 2017- by Steven E. Greer, MD Off the radar of Wall Street analysts is a new paper in the NEJM that shows mechanical heart valves, both aortic and mitral, impart much lower mortality than tissue valves in the … Continue reading
Posted in - Medical Devices, - NEJM, Cardiac surgery, Cardiology
Leave a comment
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)
November 20, 2017- Interviewed by Steven E. Greer, MD We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM
Posted in - NEJM, Cardiac surgery, Emory, Oncology
Leave a comment
CT-scan screening for heart disease fails to show benefit
March 23, 2015- Interviewed by Steven E. Greer, MD We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke.
Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology
Leave a comment
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab
Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology
Leave a comment
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
January 12, 2017- Interviewed by Steven E. Greer, MD Jonathan Strosberg, MD of
Posted in - NEJM, Oncology
Leave a comment
The bionic pancreas data
July 2, 2014- Interviewed by Steven E. Greer, MD The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas”
The ACA’s THC program: A pilot program to fund residency training outside of the traditional hospital setting
September 6, 2016- Interviewed by Steven E. Greer, MD
Posted in - NEJM, - Policy, CMS, George Washington Univ
Leave a comment
Ibrance (palbociclib) to treat advanced breast cancer
November 28, 2016- Interviewed by Steven E. Greer, MD We interviewed Richard Finn,
10-year follow-up on the CREST carotid stenting trial
March 4, 2016- Interviewed by Steven E. Greer, MD The 10-year follow-up data on the CREST carotid stenting vs. CEA trail were published
A second blow to Atul Gawande (and Obamacare)
December 15, 2015- by Steven E. Greer, MD Atul Gawande, MD, a surgeon working at one of the Harvard affiliated hospitals, wrote an influential essay in the
The telomerase inhibitor Imetelstat developed by Geron
September 9, 2015-
Posted in - Biotech, - NEJM, Oncology
Leave a comment
Are the new PCSK9 cholesterol lowering drugs worth the high cost?
December 16, 2015- Interviewed by Steven E. Greer, MD
Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA
Leave a comment
The NEJM editorial board blew it on anti-quarantine Ebola essay
October 28, 2014- By Steven E. Greer, MD Jeffrey Drazen and the other editors of the New England Journal of Medicine rushed out an opinion
Posted in - NEJM, - Opinion, - Policy, Infectious disease
Leave a comment
Cutting through the hype surrounding gluten
October 19, 2014- Interviewed by Steven E. Greer, MD Did you know that one out of three Americans think that they are “gluten intolerant”. Of those 100
Posted in - NEJM, - Policy, Gastroenterology and liver, Pediatrics
Leave a comment
Long-term contraception is effective and underutilized
October 1, 2014- Interviewed by Steven E. Greer Jeffrey F. Peipert, M.D., Ph.D. of Washington university discusses his original article in the NEJM
Single-pill combo regimens for HIV
July 28, 2014- Interviewed by Steven E. Greer, MD Rajesh Tim Gandhi, MD of the Massachusetts General Hospital discusses the NEJM review paper
Posted in - NEJM, Harvard, Infectious disease
Leave a comment
Jay Skyler discusses the recent bionic pancreas data
June 22, 2014- By Steven E. Greer, MD This week, the mainstream press reported on the “bionic pancreas” data published in the NEJM
The Massachusetts General trauma response to the Boston bombings
May 3, 2013- Interviewed by Steven E. Greer, MD Paul Biddinger, MD, Medical Director for Emergency Preparedness, Massachusetts General
Posted in - NEJM, - Policy, Trauma Surgery
Leave a comment
Review of the CREST trial of carotid stenting
The CREST trial, published earlier this year, was the latest large-scale, randomized, controlled